Business

Shire PLC, Boston Children’s Hospital announce research collaboration

Advertisement

Shire PLC, an Irish drug company that runs its Human Genetic Therapies division from Lexington, and Boston Children’s Hospital said Tuesday that they will collaborate on researching treatments for rare pediatric diseases.

Under the terms of the three-year agreement, Shire will make an initial upfront payment to Boston Children’s and will have the opportunity to fund selected research programs, the two companies said in a press release. The amount of the upfront payment was not disclosed in the release.

Boston Children’s is the primary pediatric teaching hospital of Harvard Medical School and the largest provider of health care to Massachusetts children.

Chris Reidy can be reached at reidy@globe.com.
Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com